FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3090752612> ?p ?o ?g. }

• W3090752612 endingPage "506" @default.
• W3090752612 startingPage "498" @default.
• W3090752612 abstract "We investigated the incidence of cardiotoxicity, its risk factors, and the clinical course of cardiac function in patients with malignant lymphoma (ML) who received a cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) regimen. Among all ML patients who received a CHOP regimen with or without rituximab from January 2008 to December 2017 in Nagoya City University hospital, 229 patients who underwent both baseline and follow-up echocardiography and had baseline left ventricular ejection fraction (LVEF) ≥50% were analyzed, retrospectively. Cardiotoxicity was defined as a ≥10% decline in LVEF and LVEF < 50%; recovery from cardiotoxicity was defined as a ≥5% increase in LVEF and LVEF ≥50%. Re-cardiotoxicity was defined as meeting the criteria of cardiotoxicity again. With a median follow-up of 1132 days, cardiotoxicity, symptomatic heart failure, and cardiovascular death were observed in 48 (21%), 30 (13%), and 5 (2%) patients, respectively. Multivariate analysis demonstrated that history of ischemic heart disease (hazard ratio (HR), 3.15; 95% CI, 1.17-8.47, P = .023) and decreased baseline LVEF (HR per 10% increase, 2.55; 95% CI, 1.49-4.06; P < .001) were independent risk factors for cardiotoxicity. Recovery from cardiotoxicity and re-cardiotoxicity were observed in 21 of 48, and six of 21, respectively. Cardiac condition before chemotherapy seemed to be most relevant for developing cardiotoxicity. Furthermore, Continuous management must be required in patients with cardiotoxicity, even after LVEF recovery." @default.
• W3090752612 created "2020-10-08" @default.
• W3090752612 creator A5002040090 @default.
• W3090752612 creator A5002201865 @default.
• W3090752612 creator A5017360616 @default.
• W3090752612 creator A5018271718 @default.
• W3090752612 creator A5018501206 @default.
• W3090752612 creator A5028575941 @default.
• W3090752612 creator A5029722966 @default.
• W3090752612 creator A5031256678 @default.
• W3090752612 creator A5036155456 @default.
• W3090752612 creator A5039702055 @default.
• W3090752612 creator A5044499778 @default.
• W3090752612 creator A5048020501 @default.
• W3090752612 creator A5056315538 @default.
• W3090752612 creator A5067280358 @default.
• W3090752612 creator A5067411756 @default.
• W3090752612 creator A5068758580 @default.
• W3090752612 creator A5073391500 @default.
• W3090752612 creator A5074863253 @default.
• W3090752612 creator A5078852881 @default.
• W3090752612 creator A5084881000 @default.
• W3090752612 date "2020-10-03" @default.
• W3090752612 modified "2023-10-13" @default.
• W3090752612 title "Clinical features of anthracycline‐induced cardiotoxicity in patients with malignant lymphoma who received a CHOP regimen with or without rituximab: A single‐center, retrospective observational study" @default.
• W3090752612 cites W148860973 @default.
• W3090752612 cites W1492360552 @default.
• W3090752612 cites W1515699320 @default.
• W3090752612 cites W1571199037 @default.
• W3090752612 cites W181903954 @default.
• W3090752612 cites W1961248591 @default.
• W3090752612 cites W1974432041 @default.
• W3090752612 cites W1995054939 @default.
• W3090752612 cites W1998141986 @default.
• W3090752612 cites W2022361916 @default.
• W3090752612 cites W2058015212 @default.
• W3090752612 cites W2101382021 @default.
• W3090752612 cites W2107401114 @default.
• W3090752612 cites W2109634728 @default.
• W3090752612 cites W2110128058 @default.
• W3090752612 cites W2112196039 @default.
• W3090752612 cites W2124559003 @default.
• W3090752612 cites W2124624517 @default.
• W3090752612 cites W2129791669 @default.
• W3090752612 cites W2129932871 @default.
• W3090752612 cites W2147646179 @default.
• W3090752612 cites W215852898 @default.
• W3090752612 cites W2161282966 @default.
• W3090752612 cites W2217739864 @default.
• W3090752612 cites W2318772898 @default.
• W3090752612 cites W2320264340 @default.
• W3090752612 cites W2465957034 @default.
• W3090752612 cites W2523697855 @default.
• W3090752612 cites W2560560709 @default.
• W3090752612 cites W2736563004 @default.
• W3090752612 cites W2756103188 @default.
• W3090752612 cites W2758590084 @default.
• W3090752612 cites W2774161211 @default.
• W3090752612 cites W2898655817 @default.
• W3090752612 cites W2916784537 @default.
• W3090752612 cites W2943871401 @default.
• W3090752612 cites W336328758 @default.
• W3090752612 cites W36650246 @default.
• W3090752612 cites W631572810 @default.
• W3090752612 doi "https://doi.org/10.1002/jha2.110" @default.
• W3090752612 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35845008" @default.
• W3090752612 hasPublicationYear "2020" @default.
• W3090752612 type Work @default.
• W3090752612 sameAs 3090752612 @default.
• W3090752612 citedByCount "2" @default.
• W3090752612 countsByYear W30907526122022 @default.
• W3090752612 countsByYear W30907526122023 @default.
• W3090752612 crossrefType "journal-article" @default.
• W3090752612 hasAuthorship W3090752612A5002040090 @default.
• W3090752612 hasAuthorship W3090752612A5002201865 @default.
• W3090752612 hasAuthorship W3090752612A5017360616 @default.
• W3090752612 hasAuthorship W3090752612A5018271718 @default.
• W3090752612 hasAuthorship W3090752612A5018501206 @default.
• W3090752612 hasAuthorship W3090752612A5028575941 @default.
• W3090752612 hasAuthorship W3090752612A5029722966 @default.
• W3090752612 hasAuthorship W3090752612A5031256678 @default.
• W3090752612 hasAuthorship W3090752612A5036155456 @default.
• W3090752612 hasAuthorship W3090752612A5039702055 @default.
• W3090752612 hasAuthorship W3090752612A5044499778 @default.
• W3090752612 hasAuthorship W3090752612A5048020501 @default.
• W3090752612 hasAuthorship W3090752612A5056315538 @default.
• W3090752612 hasAuthorship W3090752612A5067280358 @default.
• W3090752612 hasAuthorship W3090752612A5067411756 @default.
• W3090752612 hasAuthorship W3090752612A5068758580 @default.
• W3090752612 hasAuthorship W3090752612A5073391500 @default.
• W3090752612 hasAuthorship W3090752612A5074863253 @default.
• W3090752612 hasAuthorship W3090752612A5078852881 @default.
• W3090752612 hasAuthorship W3090752612A5084881000 @default.
• W3090752612 hasBestOaLocation W30907526121 @default.
• W3090752612 hasConcept C126322002 @default.
• W3090752612 hasConcept C164705383 @default.
• W3090752612 hasConcept C207103383 @default.
• W3090752612 hasConcept C2776694085 @default.

• next